Anti-Cancer Drugs by Andrew M Bambala - University of Zambia - Pharmacology-unza

Description

This comprehensive academic presentation provides a detailed overview of anticancer drugs, authored by Andrew M Bambala for third-year Pharmacology and Toxicology students in the Biomedical Sciences programme at the University of Zambia. It begins by defining cancer and neoplasia, outlining the aims of cancer treatment, and categorising cancers based on cell origin. The document explains the pathogenesis of cancer, focusing on genetic changes such as the activation of proto-oncogenes and inactivation of tumour suppressor genes. It systematically classifies anticancer drugs according to chemical structure, biochemical mechanism, and cell cycle specificity, detailing the phases of the cell cycle and the concept of Growth Fraction. The core of the material covers major drug classes including antimetabolites like methotrexate and 5-fluorouracil, alkylating agents, platinum compounds, antitumour antibiotics, microtubule inhibitors such as vinca alkaloids and taxanes, and hormonal agents. For each category, it discusses mechanisms of action, indications, and common adverse effects, while also addressing critical issues like drug resistance and general toxicity. This authoritative resource is essential for university students in pharmacology, biomedical sciences, and medicine, providing structured, exam-focused content to support understanding of chemotherapeutic principles, drug mechanisms, and therapeutic applications for exam preparation and advanced study. Download these detailed notes to enhance your mastery of oncological pharmacology.